Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
There is an urgent need to develop a vaccine for prophylaxis of COVID-19 and for other future epidemics. This review describes patented vaccines for SARS and MERS-CoV and vaccines developed and approved for emergency use against the new coronavirus